Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03042416 : 18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety
PhasePhase 3
AgesMin: N/A Max: N/A
Eligibility
Inclusion Criteria:

- 1. Pediatric patients (less than 17 years old) with congenital hyperinsulinism

- 2. Pediatric patients (less than 17 years old) with neuroblastoma

- 3. Pediatric patients (less than 17 years old) or Adult patients (17 or older) with
known or clinically suspected neuroendocrine tumor outside of the pancreas

- 4. Adult patients (17 or older) with a clinical suspicion of Parkinson's disease.

- 5. Pediatric (less than 17 years old) or Adult patients (17 or older) with primary
brain tumors

Exclusion Criteria:

- Unable to obtain consent

- Weight > 250 kg (weight limitation of PET/CT scanner)

- Adult patients unable to lie flat for 20-30 minutes to complete the PET/CT scan

- Young pediatric patients (less than 10 years old) who are unable to lie flat for 20-30
minutes and for whom clinical sedation is contraindicated (as determined by a
pediatric anaesthesiologist)

- Pregnancy

- Lack of intravenous access
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03042416      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740